We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

160 hedge funds and large institutions have $621M invested in Meridian Bioscience Inc in 2014 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 59 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

1% less funds holding

Funds holding: 161 → 160 (-1)

11% less capital invested

Capital invested by funds: $695M → $621M (-$74.1M)

12% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 59

96% less call options, than puts

Call options by funds: $41K | Put options by funds: $1.06M

Holders
160
Holders Change
-1
Holders Change %
-0.62%
% of All Funds
4.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
52
Reduced
59
Closed
22
Calls
$41K
Puts
$1.06M
Net Calls
-$1.02M
Net Calls Change
+$782K

Top Buyers

Rank Fund Capital Flow
1
PP
Prudential plc
United Kingdom
+$5.95M
2
Millennium Management
Millennium Management
New York
+$4.64M
3
BFA
BlackRock Fund Advisors
California
+$3.97M
4
Morgan Stanley
Morgan Stanley
New York
+$3.62M
5
Wells Fargo
Wells Fargo
California
+$3.53M

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$25.5M
2
ACM
Atlanta Capital Management
Georgia
-$9.92M
3
PIM
Perkins Investment Management
Illinois
-$8.45M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$8.21M
5
CAI
Capital Advisors Inc
Oklahoma
-$3.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$4.15M +$37K +2,157 +0.9%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$4.02M +$195K +11,365 +5%
Citadel Advisors
28
Citadel Advisors
Florida
$3.68M +$1.4M +81,602 +57%
Ameriprise
29
Ameriprise
Minnesota
$3.1M +$99.5K +5,799 +3%
Two Sigma Investments
30
Two Sigma Investments
New York
$3.01M +$2.59M +150,724 +470%
MC
31
Menta Capital
California
$2.91M +$854K +49,790 +39%
GF
32
Gabelli Funds
New York
$2.8M +$515K +30,000 +21%
BA
33
Broadview Advisors
Wisconsin
$2.78M +$11.2K +650 +0.4%
CIS
34
Connors Investor Services
Pennsylvania
$2.53M +$769K +44,850 +41%
TCIM
35
TIAA CREF Investment Management
New York
$2.52M -$143K -8,330 -5%
Charles Schwab
36
Charles Schwab
California
$2.43M +$164K +9,550 +7%
New York State Teachers Retirement System (NYSTRS)
37
New York State Teachers Retirement System (NYSTRS)
New York
$2.42M – – –
GI
38
GAMCO Investors
Connecticut
$2.29M -$17.2K -1,000 -0.7%
BIM
39
BlackRock Investment Management
Delaware
$2.24M -$11.2K -653 -0.5%
TA
40
Teton Advisors
New York
$2.22M +$17.2K +1,000 +0.7%
SFM
41
Systematic Financial Management
New Jersey
$2.19M +$2.28M +132,825 New
Invesco
42
Invesco
Georgia
$1.89M -$66.8K -3,894 -3%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$1.88M -$8.21M -478,584 -81%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$1.75M -$39.5K -2,300 -2%
ZAM
45
Zevin Asset Management
Massachusetts
$1.72M +$36.6K +2,135 +2%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$1.61M -$77.4K -4,510 -4%
KAM
47
Keeley Asset Management
Illinois
$1.56M -$58.3K -3,400 -3%
Prudential Financial
48
Prudential Financial
New Jersey
$1.52M -$10.3K -600 -0.6%
AllianceBernstein
49
AllianceBernstein
Tennessee
$1.42M – – –
NFA
50
Nationwide Fund Advisors
Ohio
$1.42M -$199K -11,627 -12%
1
2
3 4 5

VIVO Hedge Fund Activity: Q4 2014 in Review

160 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q4 2014, worth a combined $621M — down 11% from $695M a quarter earlier.

Fund positioning in VIVO was balanced in Q4 2014: 22 funds opened new positions, 22 closed out, 52 added to existing stakes and 59 trimmed.

The largest buyer was Prudential plc, adding an estimated $5.95M. The largest seller was Bank of New York Mellon, cutting an estimated $25.5M.

  • 160 institutional investors held Meridian Bioscience Inc (VIVO) as of Q4 2014, down from 161 in Q3 2014.
  • Funds reported $621M of Meridian Bioscience Inc stock for Q4 2014, down 11% quarter-over-quarter.
  • 22 funds opened new Meridian Bioscience Inc positions in Q4 2014 and 22 closed out, a net change of 0 holders.
  • The largest Meridian Bioscience Inc buyer in Q4 2014 was Prudential plc, an estimated $5.95M added.
  • The largest Meridian Bioscience Inc seller in Q4 2014 was Bank of New York Mellon, an estimated $25.5M sold.

Based on aggregated 13F filings for Q4 2014.